S01 Acromegaly: Genetics to Management

Program: Symposia
Clinical Session
Thursday, March 5, 2015: 9:30 AM-11:00 AM
Room 20A (San Diego Convention Center)
**This session is eligible for CME credit**

Supported by Ipsen Biopharmaceuticals, Inc.

Chair:
Andrea Lynn Utz, MD, PHD, Vanderbilt University, Nashville, TN

Disclosures:
ALU: Principal Investigator, Novartis Pharmaceuticals, Principal Investigator, Ipsen. Disclosure Not Provided: WD
9:30 AM
Márta Korbonits, MD, PhD., Dept. of Endocrinology, Barts and the London School of Medicine, London, United Kingdom
Disclosure: MK: Principal Investigator, Pfizer, Inc., Medical Advisory Board Member, Pfizer, Inc..
10:00 AM
Philippe Chanson, MD, Institut National de la Santé et de la Recherche Médicale U693,, Univ Paris-Sud, UMR-S693, Le Kremlin Bicêtre, France, Assistance Publique-Hôpitaux de Paris, Hôpital de Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Le Kremlin Bicêtre, Paris, France, Le Kremlin-Bicêtre, France
Disclosure: PC: Clinical Researcher, Pfizer, Inc., Clinical Researcher, Novartis Pharmaceuticals, Clinical Researcher, Ipsen, Clinical Researcher, Italfarmaco.
10:30 AM
Michael Buchfelder, MD PhD, Department of Neurosurgery, University Hospital Erlangen, Erlangen, Germany
Disclosure: MB: Investigator, Pfizer, Inc., Speaker, Novartis Pharmaceuticals, Speaker, Ipsen, Speaker, Novo Nordisk.
See more of: Symposia